Gastric Motility Drugs - Global and China Top Players Market Share and Ranking 2024
Gastric motility drugs, also known as prokinetic drugs, are drugs that promote the forward movement of gastrointestinal contents. When gastric motility is low, the emptying of gastric contents is delayed, which can cause many gastrointestinal diseases, such as nausea, vomiting, heartburn, postprandial discomfort, dyspepsia, etc., and can cause gastroesophageal reflux, leading to esophageal ulcer. Gastric motility drugs are used clinically to treat related diseases, such as reflux symptoms, reflux esophagitis, dyspepsia, intestinal obstruction and other common diseases.
This report studies and analyses global Gastric Motility Drugs status and future trends, helps the client to determine the Gastric Motility Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Gastric Motility Drugs, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Gastric Motility Drugs market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Gastric Motility Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Gastric Motility Drugs sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Gastric Motility Drugs key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Gastric Motility Drugs key producing regions, capacity, production, and year over year growth
(6) Gastric Motility Drugs industry chains, upstream, midstream and downstream
According to latest study, the global market for Gastric Motility Drugs should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Gastric Motility Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Gastric Motility Drugs market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Chronic Gastritis grew percent to account for percent of the total market sales, and Reflux Esophagitis grew percent.
Market segment by players, this report covers
Johnson & Johnson
Sumitomo Dainippon
Sanofi
Pfizer
Teva
GrupoFarma
Abbott
Kyowa Kirin
Sigma-Tau Group
Wilmington
Chengdu Kanghong Pharmaceutical Group Co.,Ltd
Lunan Pharmaceutical Group Corporation
Hansoh Pharmaceutical Group Company Limited
Shanghai Sine Pharmaceutical Laboratories Co., Ltd
Disha Pharmaceutical Group Co., Ltd
Xian Janssen Pharmaceutical Ltd
Market segment by Type, covers
Monotherapy
Poly Pill
Market segment by Application, can be divided into
Chronic Gastritis
Reflux Esophagitis
Functional Dyspepsia
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Gastric Motility Drugs product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Gastric Motility Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Gastric Motility Drugs market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Gastric Motility Drugs, percent & CAGR, 2018-2029
Chapter 5: Gastric Motility Drugs industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Gastric Motility Drugs Definition
1.2 Global Gastric Motility Drugs Market Size and Forecast
1.2.1 By Consumption Value, Global Gastric Motility Drugs Market Size，2018-2029
1.2.2 By Sales Quantity, Global Gastric Motility Drugs Market Size，2018-2029
1.2.3 Global Gastric Motility Drugs Average Selling Price (ASP)，2018-2029
1.3 China Gastric Motility Drugs Market Size and Forecast
1.3.1 By Consumption Value, China Gastric Motility Drugs Market Size，2018-2029
1.3.2 By Sales Quantity, China Gastric Motility Drugs Market Size，2018-2029
1.3.3 China Gastric Motility Drugs Average Selling Price (ASP)， 2018-2029
1.4 Share of China Gastric Motility Drugs Market with Respect to the Global Market
1.4.1 By Consumption Value, China Gastric Motility Drugs Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Gastric Motility Drugs Market Share in Global, 2018-2029
1.4.3 Gastric Motility Drugs Market Size: China VS Global, 2018-2029
1.5 Gastric Motility Drugs Market Dynamics
1.5.1 Gastric Motility Drugs Market Drivers
1.5.2 Gastric Motility Drugs Market Restraints
1.5.3 Gastric Motility Drugs Industry Trends
1.5.4 Gastric Motility Drugs Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Gastric Motility Drugs, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Gastric Motility Drugs, Global Market Share by Company, 2018-2023
2.3 Gastric Motility Drugs Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Gastric Motility Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Gastric Motility Drugs Concentration Ratio
2.6 Global Gastric Motility Drugs Mergers & Acquisitions, Expansion Plans
2.7 Global Gastric Motility Drugs Manufacturers Product Type
2.8 Head Office and Gastric Motility Drugs Production Site of Key Manufacturer
2.9 Gastric Motility Drugs Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Gastric Motility Drugs, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Gastric Motility Drugs, China Market Share by Company, 2018-2023
3.3 China Gastric Motility Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Gastric Motility Drugs Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Gastric Motility Drugs Capacity by Region
4.3 Global Gastric Motility Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Gastric Motility Drugs Production by Region, 2018-2029
4.5 Global Gastric Motility Drugs Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Gastric Motility Drugs Industry Chain
5.2 Gastric Motility Drugs Upstream Analysis
5.2.1 Gastric Motility Drugs Core Raw Materials
5.2.2 Main Manufacturers of Gastric Motility Drugs Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Gastric Motility Drugs Production Mode
5.6 Gastric Motility Drugs Procurement Model
5.7 Gastric Motility Drugs Industry Sales Model and Sales Channels
5.7.1 Gastric Motility Drugs Sales Model
5.7.2 Gastric Motility Drugs Typical Distributors
6 Sights by Type
6.1 Gastric Motility Drugs Classification
6.1.1 Monotherapy
6.1.2 Poly Pill
6.2 By Type, Global Gastric Motility Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Gastric Motility Drugs Consumption Value, 2018-2029
6.4 By Type, Global Gastric Motility Drugs Sales Quantity, 2018-2029
6.5 By Type, Global Gastric Motility Drugs Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Gastric Motility Drugs Segment by Application
7.1.1 Chronic Gastritis
7.1.2 Reflux Esophagitis
7.1.3 Functional Dyspepsia
7.1.4 Others
7.2 By Application, Global Gastric Motility Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Gastric Motility Drugs Consumption Value, 2018-2029
7.4 By Application, Global Gastric Motility Drugs Sales Quantity, 2018-2029
7.5 By Application, Global Gastric Motility Drugs Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Gastric Motility Drugs Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Gastric Motility Drugs Consumption Value, 2018-2029
8.3 By Region, Global Gastric Motility Drugs Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Gastric Motility Drugs & Forecasts, 2018-2029
8.4.2 By Country, North America Gastric Motility Drugs Market Size Market Share
8.5 Europe
8.5.1 Europe Gastric Motility Drugs Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Gastric Motility Drugs Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Gastric Motility Drugs Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Gastric Motility Drugs Market Size Market Share
8.7 South America
8.7.1 South America Gastric Motility Drugs Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Gastric Motility Drugs Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Gastric Motility Drugs Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Gastric Motility Drugs Consumption Value, 2018-2029
9.3 By Country, Global Gastric Motility Drugs Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Gastric Motility Drugs Market Size, 2018-2029
9.4.2 By Type, U.S. Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Gastric Motility Drugs Market Size, 2018-2029
9.5.2 By Type, Europe Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Gastric Motility Drugs Market Size, 2018-2029
9.6.2 By Type, China Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Gastric Motility Drugs Market Size, 2018-2029
9.7.2 By Type, Japan Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Gastric Motility Drugs Market Size, 2018-2029
9.8.2 By Type, South Korea Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Gastric Motility Drugs Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Gastric Motility Drugs Market Size, 2018-2029
9.10.2 By Type, India Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Gastric Motility Drugs Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
10.1.2 Johnson & Johnson Gastric Motility Drugs Models, Specifications, and Application
10.1.3 Johnson & Johnson Gastric Motility Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Johnson & Johnson Company Profile and Main Business
10.1.5 Johnson & Johnson Recent Developments
10.2 Sumitomo Dainippon
10.2.1 Sumitomo Dainippon Company Information, Head Office, Market Area, and Industry Position
10.2.2 Sumitomo Dainippon Gastric Motility Drugs Models, Specifications, and Application
10.2.3 Sumitomo Dainippon Gastric Motility Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Sumitomo Dainippon Company Profile and Main Business
10.2.5 Sumitomo Dainippon Recent Developments
10.3 Sanofi
10.3.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.3.2 Sanofi Gastric Motility Drugs Models, Specifications, and Application
10.3.3 Sanofi Gastric Motility Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Sanofi Company Profile and Main Business
10.3.5 Sanofi Recent Developments
10.4 Pfizer
10.4.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.4.2 Pfizer Gastric Motility Drugs Models, Specifications, and Application
10.4.3 Pfizer Gastric Motility Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Pfizer Company Profile and Main Business
10.4.5 Pfizer Recent Developments
10.5 Teva
10.5.1 Teva Company Information, Head Office, Market Area, and Industry Position
10.5.2 Teva Gastric Motility Drugs Models, Specifications, and Application
10.5.3 Teva Gastric Motility Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Teva Company Profile and Main Business
10.5.5 Teva Recent Developments
10.6 GrupoFarma
10.6.1 GrupoFarma Company Information, Head Office, Market Area, and Industry Position
10.6.2 GrupoFarma Gastric Motility Drugs Models, Specifications, and Application
10.6.3 GrupoFarma Gastric Motility Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 GrupoFarma Company Profile and Main Business
10.6.5 GrupoFarma Recent Developments
10.7 Abbott
10.7.1 Abbott Company Information, Head Office, Market Area, and Industry Position
10.7.2 Abbott Gastric Motility Drugs Models, Specifications, and Application
10.7.3 Abbott Gastric Motility Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Abbott Company Profile and Main Business
10.7.5 Abbott Recent Developments
10.8 Kyowa Kirin
10.8.1 Kyowa Kirin Company Information, Head Office, Market Area, and Industry Position
10.8.2 Kyowa Kirin Gastric Motility Drugs Models, Specifications, and Application
10.8.3 Kyowa Kirin Gastric Motility Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Kyowa Kirin Company Profile and Main Business
10.8.5 Kyowa Kirin Recent Developments
10.9 Sigma-Tau Group
10.9.1 Sigma-Tau Group Company Information, Head Office, Market Area, and Industry Position
10.9.2 Sigma-Tau Group Gastric Motility Drugs Models, Specifications, and Application
10.9.3 Sigma-Tau Group Gastric Motility Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Sigma-Tau Group Company Profile and Main Business
10.9.5 Sigma-Tau Group Recent Developments
10.10 Wilmington
10.10.1 Wilmington Company Information, Head Office, Market Area, and Industry Position
10.10.2 Wilmington Gastric Motility Drugs Models, Specifications, and Application
10.10.3 Wilmington Gastric Motility Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Wilmington Company Profile and Main Business
10.10.5 Wilmington Recent Developments
10.11 Chengdu Kanghong Pharmaceutical Group Co.,Ltd
10.11.1 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Information, Head Office, Market Area, and Industry Position
10.11.2 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Models, Specifications, and Application
10.11.3 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Profile and Main Business
10.11.5 Chengdu Kanghong Pharmaceutical Group Co.,Ltd Recent Developments
10.12 Lunan Pharmaceutical Group Corporation
10.12.1 Lunan Pharmaceutical Group Corporation Company Information, Head Office, Market Area, and Industry Position
10.12.2 Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Models, Specifications, and Application
10.12.3 Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Lunan Pharmaceutical Group Corporation Company Profile and Main Business
10.12.5 Lunan Pharmaceutical Group Corporation Recent Developments
10.13 Hansoh Pharmaceutical Group Company Limited
10.13.1 Hansoh Pharmaceutical Group Company Limited Company Information, Head Office, Market Area, and Industry Position
10.13.2 Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Models, Specifications, and Application
10.13.3 Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Hansoh Pharmaceutical Group Company Limited Company Profile and Main Business
10.13.5 Hansoh Pharmaceutical Group Company Limited Recent Developments
10.14 Shanghai Sine Pharmaceutical Laboratories Co., Ltd
10.14.1 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Information, Head Office, Market Area, and Industry Position
10.14.2 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Models, Specifications, and Application
10.14.3 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Profile and Main Business
10.14.5 Shanghai Sine Pharmaceutical Laboratories Co., Ltd Recent Developments
10.15 Disha Pharmaceutical Group Co., Ltd
10.15.1 Disha Pharmaceutical Group Co., Ltd Company Information, Head Office, Market Area, and Industry Position
10.15.2 Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Models, Specifications, and Application
10.15.3 Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Disha Pharmaceutical Group Co., Ltd Company Profile and Main Business
10.15.5 Disha Pharmaceutical Group Co., Ltd Recent Developments
10.16 Xian Janssen Pharmaceutical Ltd
10.16.1 Xian Janssen Pharmaceutical Ltd Company Information, Head Office, Market Area, and Industry Position
10.16.2 Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Models, Specifications, and Application
10.16.3 Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Xian Janssen Pharmaceutical Ltd Company Profile and Main Business
10.16.5 Xian Janssen Pharmaceutical Ltd Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Gastric Motility Drugs Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Gastric Motility Drugs Market Restraints
Table 3. Gastric Motility Drugs Market Trends
Table 4. Gastric Motility Drugs Industry Policy
Table 5. Global Gastric Motility Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Gastric Motility Drugs Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Gastric Motility Drugs Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Gastric Motility Drugs Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Gastric Motility Drugs Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Gastric Motility Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Gastric Motility Drugs Mergers & Acquisitions, Expansion Plans
Table 12. Global Gastric Motility Drugs Manufacturers Product Type
Table 13. Head Office and Gastric Motility Drugs Production Site of Key Manufacturer
Table 14. Gastric Motility Drugs Capacity of Major Manufacturers and Future Plan
Table 15. China Gastric Motility Drugs Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Gastric Motility Drugs Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Gastric Motility Drugs Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Gastric Motility Drugs Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Gastric Motility Drugs Production by Region, 2018-2023, (K Units)
Table 20. Global Gastric Motility Drugs Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Gastric Motility Drugs Upstream (Raw Materials)
Table 22. Global Gastric Motility Drugs Typical Customers
Table 23. Gastric Motility Drugs Typical Distributors
Table 24. By Type, Global Gastric Motility Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Gastric Motility Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Gastric Motility Drugs Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Gastric Motility Drugs Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Gastric Motility Drugs Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Gastric Motility Drugs Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Gastric Motility Drugs Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Gastric Motility Drugs Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Gastric Motility Drugs Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Gastric Motility Drugs Sales Quantity Market Share, 2018-2029
Table 34. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
Table 35. Johnson & Johnson Gastric Motility Drugs Models, Specifications, and Application
Table 36. Johnson & Johnson Gastric Motility Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Johnson & Johnson Company Profile and Main Business
Table 38. Johnson & Johnson Recent Developments
Table 39. Sumitomo Dainippon Company Information, Head Office, Market Area, and Industry Position
Table 40. Sumitomo Dainippon Gastric Motility Drugs Models, Specifications, and Application
Table 41. Sumitomo Dainippon Gastric Motility Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Sumitomo Dainippon Company Profile and Main Business
Table 43. Sumitomo Dainippon Recent Developments
Table 44. Sanofi Company Information, Head Office, Market Area, and Industry Position
Table 45. Sanofi Gastric Motility Drugs Models, Specifications, and Application
Table 46. Sanofi Gastric Motility Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Sanofi Company Profile and Main Business
Table 48. Sanofi Recent Developments
Table 49. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 50. Pfizer Gastric Motility Drugs Models, Specifications, and Application
Table 51. Pfizer Gastric Motility Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Pfizer Company Profile and Main Business
Table 53. Pfizer Recent Developments
Table 54. Teva Company Information, Head Office, Market Area, and Industry Position
Table 55. Teva Gastric Motility Drugs Models, Specifications, and Application
Table 56. Teva Gastric Motility Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Teva Company Profile and Main Business
Table 58. Teva Recent Developments
Table 59. GrupoFarma Company Information, Head Office, Market Area, and Industry Position
Table 60. GrupoFarma Gastric Motility Drugs Models, Specifications, and Application
Table 61. GrupoFarma Gastric Motility Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. GrupoFarma Company Profile and Main Business
Table 63. GrupoFarma Recent Developments
Table 64. Abbott Company Information, Head Office, Market Area, and Industry Position
Table 65. Abbott Gastric Motility Drugs Models, Specifications, and Application
Table 66. Abbott Gastric Motility Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Abbott Company Profile and Main Business
Table 68. Abbott Recent Developments
Table 69. Kyowa Kirin Company Information, Head Office, Market Area, and Industry Position
Table 70. Kyowa Kirin Gastric Motility Drugs Models, Specifications, and Application
Table 71. Kyowa Kirin Gastric Motility Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Kyowa Kirin Company Profile and Main Business
Table 73. Kyowa Kirin Recent Developments
Table 74. Sigma-Tau Group Company Information, Head Office, Market Area, and Industry Position
Table 75. Sigma-Tau Group Gastric Motility Drugs Models, Specifications, and Application
Table 76. Sigma-Tau Group Gastric Motility Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Sigma-Tau Group Company Profile and Main Business
Table 78. Sigma-Tau Group Recent Developments
Table 79. Wilmington Company Information, Head Office, Market Area, and Industry Position
Table 80. Wilmington Gastric Motility Drugs Models, Specifications, and Application
Table 81. Wilmington Gastric Motility Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Wilmington Company Profile and Main Business
Table 83. Wilmington Recent Developments
Table 84. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Information, Head Office, Market Area, and Industry Position
Table 85. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Models, Specifications, and Application
Table 86. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Gastric Motility Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Company Profile and Main Business
Table 88. Chengdu Kanghong Pharmaceutical Group Co.,Ltd Recent Developments
Table 89. Lunan Pharmaceutical Group Corporation Company Information, Head Office, Market Area, and Industry Position
Table 90. Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Models, Specifications, and Application
Table 91. Lunan Pharmaceutical Group Corporation Gastric Motility Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Lunan Pharmaceutical Group Corporation Company Profile and Main Business
Table 93. Lunan Pharmaceutical Group Corporation Recent Developments
Table 94. Hansoh Pharmaceutical Group Company Limited Company Information, Head Office, Market Area, and Industry Position
Table 95. Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Models, Specifications, and Application
Table 96. Hansoh Pharmaceutical Group Company Limited Gastric Motility Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Hansoh Pharmaceutical Group Company Limited Company Profile and Main Business
Table 98. Hansoh Pharmaceutical Group Company Limited Recent Developments
Table 99. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Information, Head Office, Market Area, and Industry Position
Table 100. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Models, Specifications, and Application
Table 101. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Gastric Motility Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Company Profile and Main Business
Table 103. Shanghai Sine Pharmaceutical Laboratories Co., Ltd Recent Developments
Table 104. Disha Pharmaceutical Group Co., Ltd Company Information, Head Office, Market Area, and Industry Position
Table 105. Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Models, Specifications, and Application
Table 106. Disha Pharmaceutical Group Co., Ltd Gastric Motility Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Disha Pharmaceutical Group Co., Ltd Company Profile and Main Business
Table 108. Disha Pharmaceutical Group Co., Ltd Recent Developments
Table 109. Xian Janssen Pharmaceutical Ltd Company Information, Head Office, Market Area, and Industry Position
Table 110. Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Models, Specifications, and Application
Table 111. Xian Janssen Pharmaceutical Ltd Gastric Motility Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Xian Janssen Pharmaceutical Ltd Company Profile and Main Business
Table 113. Xian Janssen Pharmaceutical Ltd Recent Developments
List of Figures
Figure 1. Gastric Motility Drugs Picture
Figure 2. Global Gastric Motility Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Gastric Motility Drugs Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Gastric Motility Drugs Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Gastric Motility Drugs Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Gastric Motility Drugs Sales Quantity (K Units) & (2018-2029)
Figure 7. China Gastric Motility Drugs Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Gastric Motility Drugs Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Gastric Motility Drugs Market Share of Global, 2018-2029
Figure 10. Global Gastric Motility Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Gastric Motility Drugs Key Participants, Market Share, 2022
Figure 12. Global Gastric Motility Drugs Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Gastric Motility Drugs Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Gastric Motility Drugs Production Market Share & Forecast by Region, 2018-2029
Figure 15. Gastric Motility Drugs Industry Chain
Figure 16. Gastric Motility Drugs Procurement Model
Figure 17. Gastric Motility Drugs Sales Model
Figure 18. Gastric Motility Drugs Sales Channels, Direct Sales, and Distribution
Figure 19. Monotherapy
Figure 20. Poly Pill
Figure 21. By Type, Global Gastric Motility Drugs Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Gastric Motility Drugs Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Gastric Motility Drugs Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Gastric Motility Drugs Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Gastric Motility Drugs Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Chronic Gastritis
Figure 27. Reflux Esophagitis
Figure 28. Functional Dyspepsia
Figure 29. Others
Figure 30. By Application, Global Gastric Motility Drugs Consumption Value, 2018-2029, US$ Million
Figure 31. By Application, Global Gastric Motility Drugs Consumption Value Market Share, 2018-2029
Figure 32. By Application, Global Gastric Motility Drugs Sales Quantity, 2018-2029, (K Units)
Figure 33. By Application, Global Gastric Motility Drugs Sales Quantity Market Share, 2018-2029
Figure 34. By Application, Global Gastric Motility Drugs Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 35. By Region, Global Gastric Motility Drugs Consumption Value Market Share, 2018-2029
Figure 36. By Region, Global Gastric Motility Drugs Sales Quantity Market Share, 2018-2029
Figure 37. North America Gastric Motility Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, North America Gastric Motility Drugs Consumption Value Market Share, 2022
Figure 39. Europe Gastric Motility Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, Europe Gastric Motility Drugs Consumption Value Market Share, 2022
Figure 41. Asia Pacific Gastric Motility Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country/Region, Asia Pacific Gastric Motility Drugs Consumption Value Market Share, 2022
Figure 43. South America Gastric Motility Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, South America Gastric Motility Drugs Consumption Value Market Share, 2022
Figure 45. Middle East & Africa Gastric Motility Drugs Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. U.S. Gastric Motility Drugs Sales Quantity, 2018-2029, (K Units)
Figure 47. By Type, U.S. Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 48. By Application, U.S. Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 49. Europe Gastric Motility Drugs Sales Quantity, 2018-2029, (K Units)
Figure 50. By Type, Europe Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 51. By Application, Europe Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 52. China Gastric Motility Drugs Sales Quantity, 2018-2029, (K Units)
Figure 53. By Type, China Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 54. By Application, China Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 55. Japan Gastric Motility Drugs Sales Quantity, 2018-2029, (K Units)
Figure 56. By Type, Japan Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 57. By Application, Japan Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 58. South Korea Gastric Motility Drugs Sales Quantity, 2018-2029, (K Units)
Figure 59. By Type, South Korea Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 60. By Application, South Korea Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 61. Southeast Asia Gastric Motility Drugs Sales Quantity, 2018-2029, (K Units)
Figure 62. By Type, Southeast Asia Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 63. By Application, Southeast Asia Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 64. India Gastric Motility Drugs Sales Quantity, 2018-2029, (K Units)
Figure 65. By Type, India Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 66. By Application, India Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 67. Middle East & Africa Gastric Motility Drugs Sales Quantity, 2018-2029, (K Units)
Figure 68. By Type, Middle East & Africa Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 69. By Application, Middle East & Africa Gastric Motility Drugs Sales Quantity Market Share, 2022 VS 2029
Figure 70. Research Methodology
Figure 71. Breakdown of Primary Interviews
Figure 72. Bottom-up and Top-down Approaches
Figure 73. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|